- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00544583
Continuous Versus Interrupted Abdominal Wall Closure After Emergency Midline Laparotomy (CONTINT)
January 26, 2010 updated by: Heidelberg University
Continuous Versus Interrupted Abdominal Wall Closure After Emergency Midline Laparotomy: CONTINT - A Randomized Controlled Study
Patients undergoing primary midline laparotomy for an emergency surgical intervention with a suspected septic focus in the abdominal cavity.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
More than 700.000 open abdominal surgeries (laparotomies) are performed each year in Germany (2).
A major surgical complication after laparotomy is abdominal fascia dehiscence which might appear either as early (burst abdomen with evisceration) or as late complication (incisional hernia).
These patients usually undergo surgery for secondary fascial closure associated with markedly increased morbidity (3) including high recurrence rates (up to 45%) (4).
The applied surgical strategy of abdominal wall closure (i.e. the combination of suture technique and material) is of high relevance for prevention of fascia dehiscence and, moreover, constitutes the main factor directly controllable by the surgeon.
While several randomized controlled trials (RCT) (3; 5-8) as well as meta-analyses (9-12) exist that address the issue of optimal fascia closure in elective laparotomies, there is no RCT dealing exclusively with the emergency setting.
As a result abdominal fascia closure is performed according to the surgeon's individual preference rather than according to evidence-based data.
Therefore, the present RCT is designed to compare the most established strategies (continuous slowly absorbable sutures and interrupted rapidly absorbable sutures) for abdominal wall closure in order to determine differences between both strategies after midline incisions.
Study Type
Interventional
Enrollment (Anticipated)
80
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Heidelberg, Germany, 69120
- Recruiting
- Department of Surgery
-
Contact:
- Nuh N Rahbari, MD
- Phone Number: + 49 6221 56 39448
- Email: nuh.rahbari@med.uni-heidelberg.de
-
Contact:
- SDGC Heidelberg
- Phone Number: +49 6221 56 6986
- Email: sdgc@med.uni-heidelberg.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Preoperative Inclusion criteria:
- Age equal or greater than 18 years
- Expected survival time more than 12 months
- Patients undergoing primary and emergency midline laparotomy (patients with prior laparoscopy (not colon resections) or minor abdominal operation (e.g. appendectomy, cholecystectomy, hysterectomy, sectio) may be included into the trial)
- Suspected septic abdominal focus (e.g. perforated stomach ulcer, perforated diverticulitis)
- Informed consent
Intraoperative inclusion criteria before closure:
- Successful source control
- Abdominal lavage
Exclusion Criteria:
Preoperative exclusion criteria:
- Participation in another intervention-trial with interference of intervention and outcome of this study
Intraoperative exclusion criteria before closure:
- Planned re-laparotomy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: A
Interrupted closure with Vicryl equivalent sutures (USP 2, 45 cm)
|
Interrupted sutures for abdominal fascia closure with Vicryl equivalent sutures (USP 2, 45 cm)
|
|
Experimental: B
Continuous closure with PDS II equivalent sutures (USP 1, 150 cm loops)
|
Continuous sutures for abdominal fascia closure with PDS II equivalent USP 1, 150 cm loops
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incisional hernia or burst abdomen within 12 months
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Quality of Life
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Nuh N Rahbari, MD, Department of surgery, university of Heidelberg
- Principal Investigator: Markus W Büchler, MD, Department of surgery, university of Heidelberg
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2007
Primary Completion (Anticipated)
April 1, 2011
Study Completion (Anticipated)
April 1, 2012
Study Registration Dates
First Submitted
October 15, 2007
First Submitted That Met QC Criteria
October 15, 2007
First Posted (Estimate)
October 16, 2007
Study Record Updates
Last Update Posted (Estimate)
January 27, 2010
Last Update Submitted That Met QC Criteria
January 26, 2010
Last Verified
January 1, 2010
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- S206/2007
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.